Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases is a research paper published in BioDrugs (2023). On theSindex it has a DataRank of 0.764. It has been cited 21 times, with 20 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0.301
From 15 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 20 citers.
National Science Foundation
Grant: 2143160
Foundation for the National Institutes of Health
Grant: T32 GM136577
NIGMS NIH HHS
Grant: T32 GM135131
Achievement Rewards for College Scientists Foundation
Allegheny Health Network
Gabrielle's Angel Foundation for Cancer Research
Johns Hopkins-AstraZeneca Scholar award
FWCI
1.88
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals